Inogen (INGN) Total Current Liabilities (2013 - 2026)
Inogen's (INGN) quarterly Total Current Liabilities came in at $61.4 million in Q1 2026, down 6.12% year-on-year from $65.5 million in Q1 2025, and down 3.29% on a QoQ basis from $63.5 million in Q4 2025.
Inogen (INGN) Total Current Liabilities (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Total Current Liabilities data on file, last reported at $61.4 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 6.12% year-over-year to $61.4 million in Q1 2026; TTM through Mar 2026 was $61.4 million, a 6.12% decrease from a year earlier, with the FY2025 full-year figure at $63.5 million, down 17.15% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $61.4 million, down from $63.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for INGN reached as high as $76.7 million in Q4 2024 and fell as low as $59.3 million in Q2 2022.
- Historically, Total Current Liabilities has averaged $66.1 million across 5 years, with a median of $65.3 million in 2022.
- Across the five-year window, Total Current Liabilities gained 21.59% in 2024 and declined 17.15% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $65.3 million in 2022, then increased by 10.94% to $72.5 million in 2023, then advanced by 5.78% to $76.7 million in 2024, then slipped by 17.15% to $63.5 million in 2025, then decreased by 3.29% to $61.4 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $61.4 million in Q1 2026, $63.5 million in Q4 2025, and $64.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | 61.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.45 Mn |
| Dec 31, 2025 | 63.54 Mn |
| Sep 30, 2025 | 64.94 Mn |
| Jun 30, 2025 | 67.07 Mn |
| Mar 31, 2025 | 65.45 Mn |
| Dec 31, 2024 | 76.69 Mn |
| Sep 30, 2024 | 72.40 Mn |
| Jun 30, 2024 | 72.19 Mn |
| Mar 31, 2024 | 73.91 Mn |
| Dec 31, 2023 | 72.50 Mn |
| Sep 30, 2023 | 60.38 Mn |
| Jun 30, 2023 | 59.37 Mn |
| Mar 31, 2023 | 63.38 Mn |
| Dec 31, 2022 | 65.35 Mn |
| Sep 30, 2022 | 65.74 Mn |
| Jun 30, 2022 | 59.34 Mn |
| Mar 31, 2022 | 59.82 Mn |
| Dec 31, 2021 | 61.51 Mn |
| Sep 30, 2021 | 59.93 Mn |
| Jun 30, 2021 | 61.84 Mn |